Evidence map›Paper›PMID 37007571›Full record

ArticleAnnals of translational medicine2023

Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?

Caterina Cusumano, Emmanuel Deshayes, Boris Guiu, Guillaume De Meeus, Sébastien Carrère, Alix Bouillin, Diana Ilonca, Marie Claude Éberlé, Sophie Guillemard, Cyril Fersing and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Caterina Cusumano *Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, Strasbourg University Hospital of Strasbourg, Strasbourg, France.
Emmanuel Deshayes *Nuclear Medicine Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Boris GuiuDepartment of Radiology, St-Eloi University Hospital, Montpellier, France.
Guillaume De MeeusSurgical Oncology Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Sébastien CarrèreSurgical Oncology Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Alix BouillinSurgical Oncology Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Diana IloncaNuclear Medicine Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Marie Claude ÉberléNuclear Medicine Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Sophie GuillemardNuclear Medicine Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Cyril FersingNuclear Medicine Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Olivia SgarburaSurgical Oncology Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
François QuénetSurgical Oncology Department, Regional Cancer Institute of Montpellier (ICM), Montpellier University, Montpellier, France.
Institut de Recherche en Cancérologie de Montpellier · FRInserm · FRCentre Hospitalier Universitaire de Montpellier · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver failure is the most threatening complication after hepatectomy for colorectal liver metastases. Recent studies indicate that liver functional evaluation by hepatobiliary scintigraphy (HBS) could be more sensitive than volumetry to predict the risk of post-hepatectomy liver failure (PHLF). The aim of this study was to evaluate the performance of Methods: This retrospective study reviewed data from all patients with colorectal liver metastases treated at Montpellier Cancer Institute between 2013 and 2020. Only patients who underwent HBS before surgery were included. The primary aim was to evaluate how the use of this functional imaging modifies the surgical management of patients with colorectal liver metastases. Results: Among the 80 patients included, 26 (32.5%) underwent two-stage hepatectomy and 13 (16.3%) repeated hepatectomies. Severe postoperative complications occurred in 16 patients (20%) and all-grade liver failure occurred in 13 patients (16.3%). Seventeen patients (21.3%) underwent major liver surgery based on sufficient mebrofenin uptake, although the retrospectively evaluated future liver remnant (FLR) volume was insufficient (<30% of total liver). None of these patients had PHLF. Conclusions: This study showed the reliability of HBS for the preoperative functional assessment of patients with colorectal liver metastases. Indeed, it allowed performing major hepatectomy safely in 20% more patients who would not have been considered for surgery on the basis of volumetric assessment.

Indexed as

future liver remnant (FLR)hepatobiliary scintigraphy (HBS)Liver metastasesmebrofenintwo stage hepatectomy

Identifiers

PMID37007571
PMCPMC10061460
OpenAlexW4324365330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.